76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Azenta Inc
Closed
SectorTechnology
30.4 -1.2
Overview
Share price change
24h
Min
29.95
Max
30.59
Income | -27M -40M |
|---|---|
Sales | -4.1M 143M |
EPS | 0.05 |
Profit margin | -28.208 |
Employees | 3,000 |
EBITDA | -8.8M -18M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +13.6% upside |
Next Earnings | 5 Aug 2025 |
|---|
Market Cap | -720M 1.3B |
|---|---|
Previous open | 31.6 |
Previous close | 30.4 |
News Sentiment
By Acuity
50%
50%
184 / 410 Technology
Azenta Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Azenta Inc Forecast
Price Target
By TipRanks
13.6% upside
12 Months Forecast
Average 35 USD 13.6%
High 40 USD
Low 30 USD
Based on 2 Wall Street analysts offering 12 month price targets forAzenta Inc - Dist in the last 3 months.
Sentiment
By Acuity
184 / 410 Technology
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Azenta Inc
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
